Hikma Pharmaceuticals PLC (LSE:HIK)
£ 18.31 0.3 (1.67%) Market Cap: 4.06 Bil Enterprise Value: 4.80 Bil PE Ratio: 27.57 PB Ratio: 2.36 GF Score: 90/100

Half Year 2020 Hikma Pharmaceuticals PLC Earnings Call (Q&A Session) Transcript

Aug 07, 2020 / 08:30AM GMT
Release Date Price: £23.93 (+10.94%)
Sigurdur Oli Olafsson
Hikma Pharmaceuticals PLC - CEO & Executive Director

So good morning, everyone, and welcome. Welcome anyway to Hikma's first half investor call. As you know, today, we will not be giving a presentation on this call as we posted it on our website at 8:00 this morning. So here today is myself, Siggi Olafsson, CEO of Hikma Pharmaceuticals. And with me is Khalid Nabilsi, the CFO of Hikma. So we will be answering questions throughout the call. I just need to read the Zoom ethics, how you ask the question. (Operator Instructions)

So with that, I just want to say we are very pleased with the results, a good start to the year. All 3 businesses performed about our expectation at the beginning of the year, many ins and outs. But why don't we start with questions. I'm happy to take anyone. Who wants to be first?

Questions & Answers

Unidentified Company Representative;Patrick Andrew Robert Wood

So we have a first question from someone on the phone. So I'm just going to unmute you. Please ask your question.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot